Dr. Kwangmin Son is the co-founder and CEO at PhAST. He is responsible for setting the vision of the company and for the overall execution of the company’s clinical development, business plan and strategic partnerships that align with the company’s strategy and product vision. Dr. Son is a recognized healthcare technology expert within the industry and was invited to present to the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) at the Department of Human and Health Services, at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022), and at the Infectious Diseases Society of America (IDSA)’s IDWeek 2022. Dr. Son received a PhD in Engineering from Massachusetts Institute of Technology (MIT), and a Bachelor of Science and Master of Science degrees in Engineering from Seoul National University in South Korea.